You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Boehringer Ingelheim
Medtronic
Express Scripts
McKesson

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Patent: 7,988,605

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,988,605
Title:Exercise machine
Abstract: A resistance exercise machine, equipped with two different types of resistance disks. Both disk types apply a frictional resistive force in one direction only, created by tension by means of a pressure plate and brake disk arrangement varied by a tension knob. One disk type, provides circular motion type exercises, by using a mounted accessory to rotate the disk repeatedly. Disk can be adjusted to any angle relative to the user, by means of the universal frame assembly. The other disk type provides motion simulation type exercises by using a remote accessory, a cable, and a rewind arm assembly. Pulling against the cable, urges a pawl to engage a gear situated on the disk\'s periphery, forcing the disk to rotate. Upon discontinuing the pull on the cable, the disk stops rotating, the pawl disengages the gear, and the rewind arm assembly rewinds the cable back onto the disk\'s periphery.
Inventor(s): Wyeroski; James Ronald (Randolph, NJ)
Assignee: Wyeroski; James Ronald (Newfoundland, NJ)
Application Number:12/798,694
Patent Claims:see list of patent claims

Details for Patent 7,988,605

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial Wyeroski; James Ronald (Newfoundland, NJ) 2029-06-04 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Harvard Business School
Moodys
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.